Health
Vinay Prasad Departs FDA Amid Regulatory Turmoil
Vinay Prasad, a controversial figure at the FDA's biologics center and key ally of Commissioner Makary, is leaving the agency.
Key Takeaways
- Vinay Prasad departing FDA's Center for Biologics Evaluation and Research
- Was key ally of Commissioner Makary's regulatory reform agenda
- Departure raises questions about continuity of FDA reform initiatives
DE
DT Editorial AI··via statnews.com